Changes in global quality of life after treatment with immune checkpoint inhibitors in patients receiving different treatment regimens for advanced stage lung cancer in the Netherlands: a 2015-2021 cohort study

Ananya Malhotra*, Erick Suazo-Zepeda, Petra C. Vinke, Geertruida H. de Bock, Willemijn J. Maas, Jeroen T.J.N. Hiltermann, Bernard Rachet, Clémence Leyrat, Manuela Quaresma

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

13 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Changes in global quality of life after treatment with immune checkpoint inhibitors in patients receiving different treatment regimens for advanced stage lung cancer in the Netherlands: a 2015-2021 cohort study'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science